Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways
Author:
Open Access
- 9 July 2021
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 11 (7) , 1002
Abstract
Neurodegenerative disorders affect fifteen percent of the world’s population and pose a significant financial burden to all nations. Cognitive impairment is the seventh leading cause of death throughout the globe. Given the enormous challenges to treat cognitive disorders, such as Alzheimer’s disease, and the inability to markedly limit disease progression, circadian clock gene pathways offer an exciting strategy to address cognitive loss. Alterations in circadian clock genes can result in age-related motor deficits, affect treatment regimens with neurodegenerative disorders, and lead to the onset and progression of dementia. Interestingly, circadian pathways hold an intricate relationship with autophagy, the mechanistic target of rapamycin (mTOR), the silent mating type information regulation 2 homolog 1 (Saccharomyces cerevisiae) (SIRT1), mammalian forkhead transcription factors (FoxOs), and the trophic factor erythropoietin. Autophagy induction is necessary to maintain circadian rhythm homeostasis and limit cortical neurodegenerative disease, but requires a fine balance in biological activity to foster proper circadian clock gene regulation that is intimately dependent upon mTOR, SIRT1, FoxOs, and growth factor expression. Circadian rhythm mechanisms offer innovative prospects for the development of new avenues to comprehend the underlying mechanisms of cognitive loss and forge ahead with new therapeutics for dementia that can offer effective clinical treatments.Keywords
Funding Information
- National Institutes of Health (NS053956)
This publication has 254 references indexed in Scilit:
- Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes MellitusArchives of internal medicine (1960), 2012
- FoxO1 Mediates an Autofeedback Loop Regulating SIRT1 ExpressionJournal of Biological Chemistry, 2011
- Circadian Control of the NAD + Salvage Pathway by CLOCK-SIRT1Science, 2009
- FoxO proteins: cunning concepts and considerations for the cardiovascular systemClinical Science, 2009
- SIRT1 Regulates Circadian Clock Gene Expression through PER2 DeacetylationCell, 2008
- OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteinsTrends in Molecular Medicine, 2008
- Raves and risks for erythropoietinCytokine & Growth Factor Reviews, 2008
- Triple play: Promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitusBiomedicine & Pharmacotherapy, 2008
- New Avenues of Exploration for ErythropoietinJAMA, 2005
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature Cell Biology, 2004